Sumitomo Pharma Co. Ltd.

In News

Special Equity Disclosure Report: Sumitomo Pharma (6.06% → 3.23%), SMBC Nikko Securities, etc. - Moomoo

Moomoo - Jun 05, 2026

Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026 - Business Wire

Business Wire - Jun 01, 2026

New Data from Sumitomo Pharma America at AUA 2026 Highlight Efficacy of Vibegron in Men Aged 75 and Older with Overactive Bladder and BPH - BioSpace

BioSpace - May 18, 2026

Sumitomo Pharma Co., Ltd. 2026 Q4 - Results - Earnings Call Presentation (OTCMKTS:DNPUF) 2026-05-19 - Seeking Alpha

Seeking Alpha - May 19, 2026

Sumitomo Pharma : Announces Organizational Change, Change in the Responsibilities of Executive Officer, and Personnel Change - marketscreener.com

marketscreener.com - Jun 01, 2026

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - BioInformant

BioInformant - Mar 11, 2026

Earnings call transcript: Sumitomo Pharma Q4 2025 sees record high net profit - Investing.com

Investing.com - May 21, 2026

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis - PR Newswire

PR Newswire - Jul 30, 2025

Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls - The Globe and Mail

The Globe and Mail - May 13, 2026

Chugai Pharmaceutical Co Ltd (4519) - MSN

MSN - May 31, 2026

Is Sumitomo Pharma (TSE:4506) Using Too Much Debt? - simplywall.st

simplywall.st - Jan 02, 2026

Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com

Bloomberg.com - Feb 19, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment